X

Healthcare startup Medinfi Grabs another Funding from International Angel Investors

Medinfi raises funds from international angel investors.

Healthcare startup Medinfi has raked up nearly Rs 80 lakhs ($125,000) from various international investors. This is the sixth round of funding for the Bengaluru based startup ever since its launch in 2014. Three of these funding (including the current one) have taken place this year. According to the reports, Medinfi will be using the fresh funds to further expand its customer base to 5 million and extend its network across 50 Indian cities by 2018.

The angel investors who participated in the current round of funding are PBS Srinivas from Middle East region, Vinod Martin & Alok Bahl from Singapore and Prijit Debnath from Germany. Besides, two existing directors of Medinfi including Dr. Ram Kumar Kakani and Hemant Kaul also participated in the current round of funding.

Medinfi was founded by Ravi Shankar Mishra as a pure-play healthcare content platform. The startup claims that it is India’s first pure play healthcare content platform that offers authentic information on nearby doctors and clinics in the vicinity.

The company currently offers its services through an Android app. It also has a mobile friendly website that offers lot of useful information on healthy lifestyle and habits. This information’s are presented through blogs that are written by highly qualified health professionals.

Mr. Ravi stated in an interview that through these informative blogs his company wants to help customers in making informed decisions on various healthcare issues.

The startup primarily earns revenue through banner ads, hyperlocal ads, healthcare analytics solutions and various other sources.

Over all, the healthcare space has garnered lot of interest from VC’s and angel investors. Some of the most well-funded healthcare startup include Practo, Portea, Mitra Biotech and MedGenome. These startups offer range of healthcare solutions from helping to find nearby doctors to offering affordable cure for life threatening diseases like cancer.

Categories: News
Girish Shetti: A writer with a passion for tech, marketing, and sports, he delivers captivating articles for the tech enthusiasts. Girish’s expertise in technology and startup analysis brings insightful content and the latest trends to our readers. He loves being the ‘first’ to know(and write) all that’s happening in the world of Tech and startups.
Related Post